{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T12:03:25Z","timestamp":1753877005803,"version":"3.41.2"},"reference-count":9,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2024,1,17]],"date-time":"2024-01-17T00:00:00Z","timestamp":1705449600000},"content-version":"vor","delay-in-days":16,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Heart Foundation"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,1,2]]},"abstract":"<jats:title>Summary<\/jats:title>\n               <jats:p>A best evidence topic in thoracic surgery was written according to a structured protocol. The question addressed was \u2018For patients with malignant pleural effusion is chemical pleurodesis with povidone-iodine as effective, safe and well tolerated as talc pleurodesis for prevention of recurrent malignant pleural effusions?\u2019. A total of 124 papers were found during the search, of which 8 represented the best evidence to answer the clinical question. The authors, journal, date, country of publication, patient group studied, study type, relevant outcomes and results of these papers were tabulated. At present, medical-grade talc is the most commonly used agent for chemical pleurodesis due to its high success rate, extensive history of clinical use and well-known side-effect profile. However, studies using povidone-iodine seek to establish it as a readily available,low-cost alternative to talc that can be easily administered through an intercostal catheter at the bedside. The summation of available evidence suggests that povidone-iodine is a safe, well-tolerated and equally efficacious agent for pleurodesis in the setting of malignant pleural effusion, when compared to talc.<\/jats:p>","DOI":"10.1093\/icvts\/ivad192","type":"journal-article","created":{"date-parts":[[2024,1,17]],"date-time":"2024-01-17T12:33:05Z","timestamp":1705494785000},"source":"Crossref","is-referenced-by-count":0,"title":["Is povidone-iodine pleurodesis as effective, safe and well tolerated as talc pleurodesis for recurrent malignant pleural effusions?"],"prefix":"10.1093","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-8053-7602","authenticated-orcid":false,"given":"Sophie A","family":"Bonser","sequence":"first","affiliation":[{"name":"Department of General Surgery, Royal Perth Hospital , Perth, WA, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4724-008X","authenticated-orcid":false,"given":"Michael Z L","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Cardiothoracic Surgery, The Canberra Hospital , Canberra, ACT, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glenn S","family":"McKay","sequence":"additional","affiliation":[{"name":"Department of Cardiothoracic Surgery, The Canberra Hospital , Canberra, ACT, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,1,16]]},"reference":[{"key":"2024012514183716500_ivad192-B1","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S1569-9293(03)00191-9","article-title":"Towards evidence-based medicine in cardiothoracic surgery: best BETS","volume":"2","author":"Dunning","year":"2003","journal-title":"Interact CardioVasc Thorac Surg"},{"key":"2024012514183716500_ivad192-B2","first-page":"CD010529","article-title":"Interventions for the management of malignant pleural effusions: a network meta-analysis","volume":"4","author":"Dipper","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"2024012514183716500_ivad192-B3","doi-asserted-by":"crossref","first-page":"4733","DOI":"10.1007\/s00520-021-06004-3","article-title":"Iodopovidone pleurodesis for malignant pleural effusions: an updated systematic review and meta-analysis","volume":"29","author":"Muthu","year":"2021","journal-title":"Support Care Cancer"},{"key":"2024012514183716500_ivad192-B4","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1111\/j.1440-1843.2011.01999.x","article-title":"A randomized controlled trial of the efficacy of cosmetic talc compared with iodopovidone for chemical pleurodesis","volume":"16","author":"Agarwal","year":"2011","journal-title":"Respirology"},{"key":"2024012514183716500_ivad192-B5","first-page":"282","article-title":"Local iodine pleurodesis versus thoracoscopic talc insufflation in recurrent malignant pleural effusion: a prospective randomized control trial","volume":"40","author":"Mohsen","year":"2011","journal-title":"Eur J Cardiothorac Surg"},{"key":"2024012514183716500_ivad192-B6","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ejcdt.2012.10.013","article-title":"Chemical pleurodesis for malignant pleural effusion","volume":"61","author":"Shouman","year":"2012","journal-title":"Egypt J Chest Dis Tuberc"},{"key":"2024012514183716500_ivad192-B7","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s13019-015-0270-5","article-title":"Povidone-iodine pleurodesis versus talc pleurodesis in preventing recurrence of malignant pleural effusion","volume":"10","author":"Ibrahim","year":"2015","journal-title":"J Cardiothorac Surg"},{"key":"2024012514183716500_ivad192-B8","first-page":"589","article-title":"A study of comparison of efficacy and safety of talc and povidone iodine for pleurodesis of malignant pleural effusions","volume":"106","author":"Das","year":"2008","journal-title":"J Indian Med Assoc"},{"key":"2024012514183716500_ivad192-B9","first-page":"897","article-title":"Betadine in chemical pleurodesis","volume":"62","author":"Nistor","year":"2014","journal-title":"Farmacia"}],"container-title":["Interdisciplinary CardioVascular and Thoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/icvts\/advance-article-pdf\/doi\/10.1093\/icvts\/ivad192\/56239171\/ivad192.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/icvts\/article-pdf\/38\/1\/ivad192\/56417749\/ivad192.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/icvts\/article-pdf\/38\/1\/ivad192\/56417749\/ivad192.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T17:02:52Z","timestamp":1706202172000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/icvts\/article\/doi\/10.1093\/icvts\/ivad192\/7564642"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,1]]},"references-count":9,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1,2]]}},"URL":"https:\/\/doi.org\/10.1093\/icvts\/ivad192","relation":{},"ISSN":["2753-670X"],"issn-type":[{"type":"electronic","value":"2753-670X"}],"subject":[],"published-other":{"date-parts":[[2024,1,1]]},"published":{"date-parts":[[2024,1,1]]},"article-number":"ivad192"}}